These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5371198)

  • 1. The influence of steroids on the skeleton.
    Overbeek GA; van Vliet NP; van der Vies J; de Visser J; Crombag FJ; Assendorp R
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):420. PubMed ID: 5371198
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of 2 anabolic steroids on "essential" delayed growth].
    Canlorbe P; Borniche P; Bader JC
    Ann Pediatr (Paris); 1969 Oct; 16(10):582-9. PubMed ID: 4311468
    [No Abstract]   [Full Text] [Related]  

  • 3. Estradienes and 2-oxaestradienes. Potent oral anabolic-androgenic agents.
    Nutting EF; Calhoun DW
    Endocrinology; 1969 Feb; 84(2):441-2. PubMed ID: 5764313
    [No Abstract]   [Full Text] [Related]  

  • 4. The action of anabolic steroids on bone in experimental animals.
    Schot LP; Schuurs AH; Kloosterboer HJ
    Wien Med Wochenschr; 1993; 143(14-15):385-7. PubMed ID: 8256453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action.
    Sharan K; Mishra JS; Swarnkar G; Siddiqui JA; Khan K; Kumari R; Rawat P; Maurya R; Sanyal S; Chattopadhyay N
    J Bone Miner Res; 2011 Sep; 26(9):2096-111. PubMed ID: 21638315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future therapeutic targets in osteoporosis.
    Deal C
    Curr Opin Rheumatol; 2009 Jul; 21(4):380-5. PubMed ID: 19461517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine alkaline and acid phosphatase activity in the rhesus monkey treated with synthetic estrogen.
    Manning JP; Tornaben JA; Schwartz E
    Am J Obstet Gynecol; 1969 Oct; 105(3):412-7. PubMed ID: 4980377
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anabolic steroids in the treatment of liver diseases].
    Mossor-Ostrowska J
    Pol Tyg Lek; 1971 Aug; 26(32):1248-51. PubMed ID: 4942579
    [No Abstract]   [Full Text] [Related]  

  • 9. Estrogen, calcium metabolism and the skeleton.
    Lindsay R; Cosman F
    Ann N Y Acad Sci; 1991; 622():307-14. PubMed ID: 2064191
    [No Abstract]   [Full Text] [Related]  

  • 10. Nitrogen-retaining steroids and their application in disease.
    Querido A; Kassenaar AA
    Adv Metab Disord; 1965; 2():79-113. PubMed ID: 4924372
    [No Abstract]   [Full Text] [Related]  

  • 11. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
    McManus JF; Davey RA; Maclean HE; Doust EA; Chiu WS; Sims NA; Bouxsein ML; Glatt V; Zajac JD; Danks JA
    Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroidal imidazole-1-carboxylic acid esters.
    Fahrenholtz KE; Boris A; Kennedy TW; Kierstead RW
    J Med Chem; 1974 Mar; 17(3):337-42. PubMed ID: 4811231
    [No Abstract]   [Full Text] [Related]  

  • 13. [Osteoporosis in clinical practice].
    Kaĭzer G
    Ortop Travmatol Protez; 1975 Jan; (1):84-7. PubMed ID: 1096010
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphometric analysis of cortical bone upon the exposure to sustained delivery of anabolic promoting agents using adult male rats as a model.
    Tramontana J; Benghuzzi H; Tucci M; Tsao A; Hughes J
    Biomed Sci Instrum; 2001; 37():293-8. PubMed ID: 11347405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical pharmacology of trienolones, a group of new anabolically actine aestrane-derivatives (4,9,11-oestratrien-17beta-ol-3-on)].
    Krüskemper HL; Morgner KD; Noell G
    Arzneimittelforschung; 1967 Apr; 17(4):449-54. PubMed ID: 5632439
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative metabolic studies with anabolic steroids].
    Nowakowski H; Schmidt HP
    Med Klin; 1966 Feb; 61(6):223-7. PubMed ID: 5982915
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction between catabolic and anabolic steroids.
    Little K
    Curr Ther Res Clin Exp; 1970 Oct; 12(10):658-76. PubMed ID: 4991099
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of anabolic steroids, salmon calcitonin and 25OH-D3 on rat bones.
    Carrozzo M; Cantatore FP; Pallante R; Pipitone V
    Panminerva Med; 1984; 26(3):185-9. PubMed ID: 6522081
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the percentage of increased spongy bone in experimental osteoporosis treated with synthetic anabolic agents].
    Carrozzo M; Pallante R; Lo Sasso F; D'Amore M
    Rev Rhum Mal Osteoartic; 1983 Jun; 50(7):501-5. PubMed ID: 6612200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical management of osteoporosis.
    Mulloy AL; Weinstein RS
    J Med Assoc Ga; 1994 Apr; 83(4):227-30. PubMed ID: 8006552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.